Alcresta Investment Reflects Omega Market Growth
This article was originally published in The Tan Sheet
Alcresta is developing omega-3 and -6 fatty acid supplements that are more easily digested and absorbable. Founders Alexey Margolin and Robert Gallotto look to repeat the success they had in 2010 when they sold an earlier nutritionals start-up for $180 million.
You may also be interested in...
FDA probes AeroShot energy canister; state cannot force pharmacists to provide Plan B; analysts boost Herbalife earnings estimates; consumers allege Gerber makes false probiotics claims; more news In Brief.